ESSA PHARMA INC (EPIX)
CA29668H7085 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 56.30M | |||
| Cash Equivalents | 35.34M | 33.70M | 57.10M | 137.80M | N/A | |||
| Marketable Securities | 106.78M | 114.37M | 110.20M | 57.10M | 22.00M | |||
| Receivables | 180.61K | 135.06K | 0.00 | 500.00K | 300.00K | |||
| Other Current Assets | 1.57M | 585.42K | 1.80M | 2.20M | 1.70M | |||
| Total Current Assets | 143.87M | 148.80M | 169.10M | 197.60M | 80.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 363.15K | 68.01K | 200.00K | 300.00K | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 257.25K | 257.25K | 300.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 620.39K | 325.25K | 400.00K | 600.00K | 300.00K | |||
| TOTAL ASSETS | 144.49M | 149.12M | 169.50M | 198.20M | 80.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Accrued Expenses | 930.74K | 1.47M | 1.40M | 2.50M | 500.00K | |||
| Accounts Payable | 2.60M | 2.03M | 1.00M | 1.40M | 700.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 3.53M | 3.50M | 2.30M | 3.90M | 1.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 275.45K | 0.00 | 100.00K | 200.00K | 100.00K | |||
| Total Non-Current Liabilities | 275.44K | 0.00 | 100.00K | 300.00K | 100.00K | |||
| TOTAL LIABILITIES | 3.81M | 3.50M | 2.40M | 4.20M | 1.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -185.43M | -179.46M | -152.90M | -117.80M | -81.00M | |||
| Additional Paid In Capital | 49.70M | 49.05M | 44.00M | 36.40M | 31.20M | |||
| Common Shares | 278.51M | 278.16M | 278.10M | 277.40M | 131.10M | |||
| Other Shareholders' Equity | -2.10M | -2.12M | -2.10M | -2.10M | -2.10M | |||
| Shares Outstanding | 44.16M | 44.10M | 44.10M | 44.00M | 32.10M | |||
| Tangible Book Value per Share | 3.19 | 3.30 | 3.79 | 4.41 | 2.47 | |||
| Total Shareholders' Equity | 140.68M | 145.63M | 167.10M | 194.00M | 79.20M | |||
| TOTAL LIABILITIES AND EQUITY | 144.49M | 149.12M | 169.50M | 198.20M | 80.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 40.75 | 42.57 | 73.52 | 50.67 | 66.92 | |||
| Return On Assets (ROA) | -17.86% | -17.83% | -20.71% | -18.57% | -29.09% | |||
| Return On Equity (ROE) | -18.34% | -18.25% | -21.01% | -18.97% | -29.61% | |||
All data in USD